Your browser doesn't support javascript.
loading
Reporting of harms in clinical trials of esketamine in depression: a systematic review.
Taillefer de Laportalière, Tanguy; Jullien, Adeline; Yrondi, Antoine; Cestac, Philippe; Montastruc, François.
Affiliation
  • Taillefer de Laportalière T; Department of Medical and Clinical Pharmacology, Centre of PharmacoVigilance and Pharmacoepidemiology, Toulouse University Hospital (CHU), Faculty of Medicine, Toulouse, France.
  • Jullien A; Department of Pharmacy, Toulouse University Hospital (CHU), Toulouse, France.
  • Yrondi A; Department of Medical Psychiatry, Toulouse University Hospital (CHU), Faculty of Medicine, Toulouse, France.
  • Cestac P; Treatment Resistant Depression Expert Center, FondaMental, Toulouse, France.
  • Montastruc F; ToNIC Toulouse NeuroImaging Center, University Paul Sabatier Toulouse, INSERM, Toulouse, France.
Psychol Med ; 53(10): 4305-4315, 2023 07.
Article in En | MEDLINE | ID: mdl-37185130
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depression / Ketamine / Antidepressive Agents Type of study: Systematic_reviews Limits: Humans Language: En Journal: Psychol Med Year: 2023 Document type: Article Affiliation country: Francia
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Depression / Ketamine / Antidepressive Agents Type of study: Systematic_reviews Limits: Humans Language: En Journal: Psychol Med Year: 2023 Document type: Article Affiliation country: Francia